What does the evidence say about Soy Protein Muscle Strength Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Soy Protein Muscle Strength Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - 1 2 1 3 Sarcopenia is a progressive and generalized skeletal muscle disorder that is highly prevalent among older adults, characterized by reduced muscle strength, low muscle quantity or quality, and impaired physical performance. [Yang Boran (2026); evidence level 1] - Previous systematic reviews and recent meta-analytic evidence suggest that combined exercise and nutritional interventions may improve muscle-related outcomes in older adults. [Yang Boran (2026); evidence level 1] - However, these previous syntheses did not specifically address whether protein or protein-related supplementation provides additional benefits when an evidence-based exercise program is already implemented. [Yang Boran (2026); evidence level 1] - The revised consensus of the European Working Group on Sarcopenia in Older People places low muscle strength at the center of case finding, using low muscle quantity or quality to confirm the diagnosis (). [Yang Boran (2026); evidence level 1] - A subsequent review included 49 RCTs and yielded a similar conclusion, observing a dose–response relationship without specifying the optima for different types (). [Li Yunxia (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.